These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11780577)

  • 41. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
    Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
    Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
    Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythropoietin and erythropoietin receptor in colorectal cancer.
    Chabowska AM; Sulkowska M; Chabowski A; Wincewicz A; Koda M; Sulkowski S
    Int J Surg Pathol; 2008 Jul; 16(3):269-76. PubMed ID: 18487221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of cathepsin D granules in normal and pathologic conditions in human prostate.
    Islam AH; Kato H; Nishizawa O; Hayama M
    Hinyokika Kiyo; 2002 Nov; 48(11):647-52. PubMed ID: 12512135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
    Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
    Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical localization of cathepsin D in colorectal tumors.
    Arao J; Fukui H; Ono Y; Ueda Y; Chiba T; Fujimori T
    Dis Colon Rectum; 2000 Mar; 43(3):396-401. PubMed ID: 10733123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical expression of cathepsin D in meningiomas.
    Castilla EA; Prayson RA; Abramovich CM; Cohen ML
    Am J Clin Pathol; 2003 Jan; 119(1):123-8. PubMed ID: 12520707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LRIG1 expression in colorectal cancer.
    Ljuslinder I; Golovleva I; Palmqvist R; Oberg A; Stenling R; Jonsson Y; Hedman H; Henriksson R; Malmer B
    Acta Oncol; 2007; 46(8):1118-22. PubMed ID: 17851870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.
    Downs LS; Lima PH; Bliss RL; Blomquist CH
    J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression of cathepsin B and its clinical importance in colorectal cancer].
    Yu B; Li SY; An P; Zuo FY; Cai HY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.
    Spindler KL; Nielsen JN; Ornskov D; Brandslund I; Jakobsen A
    Acta Oncol; 2007; 46(8):1113-7. PubMed ID: 17851837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of some lysosomal enzymes in serum and in tumors of patients with squamous cell lung carcinoma.
    Woźniak A; Drewa T; Rozwodowska M; Drewa G; Lambrecht W; Wiśniewska I
    Neoplasma; 2002; 49(1):10-5. PubMed ID: 12044053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
    J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
    Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
    Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.